To determine and compare outcomes with accepted benchmarks in burn care at 6 academic burn centers. Background: Since the 1960s, US morbidity and mortality rates have declined tremendously for burn patients, likely related to improvements in surgical and critical care treatment. We describe the baseline patient characteristics and well-defined outcomes for major burn injuries. Methods: We followed 300 adults and 241 children from 2003 to 2009 through hospitalization, using standard operating procedures developed at study onset. We created an extensive database on patient and injury characteristics, anatomic and physiological derangement, clinical treatment, and outcomes. These data were compared with existing benchmarks in burn care. Results: Study patients were critically injured, as demonstrated by mean % total body surface area (TBSA) (41.2 ± 18.3 for adults and 57.8 ± 18.2 for children) and presence of inhalation injury in 38% of the adults and 54.8% of the children. Mortality in adults was 14.1% for those younger than 55 years and 38.5% for those aged 55 years and older. Mortality in patients younger than 17 years was 7.9%. Overall, the multiple organ failure rate was 27%. When controlling for age and % TBSA, presence of inhalation injury continues to be significant.
B urn injuries accounted for an estimated 603,000 visits to US emergency departments in 2010 1 and an estimated 50,000 hospital admissions. 2 In those patients hospitalized for burn injury, the cost of fire and nonfire burn injuries totaled $1 billion. 3 Survival from extensive burn injuries today is much higher than seen in the United States during the 1960s. 4, 5 At that time, it was common for patients with burns with more than 20% total body surface area (TBSA) to die early from the initial cutaneous burn injury, or later from infections or other complications related to the injury. With advances in surgical and critical care management and higher likelihood of treatment in centers specializing in burn care, survival after serious and lifethreatening burn injury has improved during the 1970s and 1980s. 6 Major burns like other significant traumatic injuries are complex to treat and often result in acute physiologic and metabolic derangements. Effective fluid resuscitation, control of infection and organ dysfunction, and management of complications are important tools to extenuate the life-threatening conditions associated with severe burn injury.
This study was designed to collect outcomes data from patients with significant burn injury (burns >20% TBSA) requiring operative treatment. It provides a homogenous, critically injured population in which to describe demographic injury and patient characteristics for major burn injuries and to identify important clinical outcomes, including multiple organ failure (MOF), infectious complications, and death.
In burn injury studies, it is common to report relatively small patient populations or historical trends within a single institution that may have been influenced by changes in clinical burn care over time. The few multicenter studies available do provide analyses of larger numbers of patients; however, generalizing from these studies may be difficult because the data are collected under various local care protocols or no protocols at all, with little to no uniform categorization with regard to definitions for diagnosis and outcomes. 7 Furthermore, burn injury databases used for clinical research typically have not been rich in physiologic data or outcomes beyond survival or death.
The Inflammation and Host Response to Injury is one of the National Institutes of Health-National Institute of General Medical Sciences large-scale, collaborative research projects ("Glue Grants"), which was funded to study the innate immune and metabolic response to serious injury. By study design, we enrolled patients who sustained major burn injuries. Standard operating procedures (SOPs) were established and implemented to promote uniform high-quality care in a
METHODS

Study Design
In this observational, prospective study conducted from May 2003 to February 2010 at 6 US burn centers, patients were enrolled if they had thermal burns with 20% TBSA or more, required operative treatment, and arrived at the participating burn center within 96 hours of injury. Patients with do-not-resuscitate orders on admission were not eligible for the study. See Supplemental Digital Content Table 1 , available at: http://links.lww.com/SLA/A518, for the inclusion and exclusion criteria. SOPs for patient treatment were developed through a series of literature reviews and comprehensive, quarterly face-toface meetings of the Glue Grant investigators.
Definition of Outcomes and Data Collection
In this study, we evaluated the relationship between baseline patient characteristics and injury severity with mortality. Eligibility screening was performed for all patients admitted to the participating burn centers. Demographic, clinical, physiologic, pathophysiologic, and outcomes data were abstracted through the hospitalization for burn injury and uploaded to an adaptation of the TrialDB 9 Web-based clinical data management system. The study investigators, relying on existing standards wherever possible, defined clinical data definitions prospectively. Trained data abstractors with a health care background participated in face-to-face meetings and conference calls to ensure uniformity of data abstraction across the centers. A dedicated data processing team was responsible for data management, curation, and storage. A clinical data manager performed ongoing quality monitoring to ensure data completeness and accuracy, which included computer-generated data queries submitted to the abstractors in the case of internal inconsistencies and missing or implausible values. A 5% random sample of subject records was selected for review during each clinical site visit; the site visit team reviewed the records for study eligibility, cause of death (if applicable), the presence or absence of infections, and other clinical complications. The institutional review board of each participating center reviewed and approved the study.
Organ dysfunction and hospital mortality were analyzed as outcomes measures in this study. Organ dysfunction assessment was performed using a widely accepted postinjury MOF score, the Denver MOF score 10, 11 (Supplemental Digital Content Table 2 , available at: http://links.lww.com/SLA/A519). MOF was defined as a Denver MOF score of 4 or more.
Acute lung injury and acute respiratory distress syndrome (ARDS) were defined according to the European-American consensus conference. 12 Other noninfectious and infectious complications were assessed by objective criteria using standardized definitions. Definitions of nosocomial infections 13 and surgical site infections 14 were those definitions used by the Centers for Disease Control and Prevention adapted such that with the exception of superficial surgical site infections, all infectious complications required the presence of a positive microbial culture.
Diagnosis of inhalation injury was determined by the standard practice of the participating institution (either by clinical his-tory/physical examination or bronchoscopy). The diagnosis of pneumonia was based on quantitative culture when available or sputum samples with counts greater than 3 + of a single organism, with radiographic evidence of pneumonia and leukocytosis.
Time to Recovery
A primary objective of this approach was to identify any organ dysfunction patterns and to identify time to recovery (TTR) using the Denver MOF score as a valid measure of morbidity. Organ recovery is relatively straightforward to identify when a failing organ requires support but less intuitive for more subtle degrees of organ dysfunction. We considered a patient recovered when all organ failure component scores were zero.
Statistical Analyses
We compared injury characteristics and outcomes of patients enrolled in the Glue Grant study with a similar cohort of patients from the National Burn Repository (NBR), the largest database of burninjured patients in the United States. 15, 16 These patients, excluding those from the Glue Grant clinical sites, sustained burn injuries during the period 2001-2009. Of the 150,709 inpatient records in the NBR database, we eliminated those records that did not match our inclusion and exclusion criteria (Supplemental Digital Content Table 1 , available at: http://links.lww.com/SLA/A518). We excluded all patients with chemical and electrical burns or unknown etiology. Glue Grant patients were matched with the remaining 4685 patients in the NBR on the basis of the following criteria: inhalation injury (present or absent); age category (0-17 years, 18-54 years, and >55 years); and TBSA burned category (20%-39%, 40%-59%, and ≥ 60%). A stratified logistic regression was performed with the resulting 4640 patients to determine the difference in mortality risk between patients in the Glue study and patients in the NBR. A previously published model 6 for estimating the probability of death from burns was used to compare observed and predicted deaths using Flora's Z-statistic. 17 The probability of death was estimated logit = −5.89 + 2.58n where n is the number of risk factors (burn size of >40% TBSA, age >60 years, or presence of inhalation injury) and logit is the natural logarithm of the ratio of the probability of dying to the probability of living. Logistic regression was used to compare mortality in our cohort with a subset of the NBR. Differences in baseline covariates between survivors and nonsurvivors for adults and children were assessed using a Wilcoxon test or Fisher exact test as appropriate. All analyses were done in SAS Version 9.2 (SAS Institute Inc., Cary, North Carolina), and 2-sided P value of 0.05 or less was considered to be evidence of statistical significance.
RESULTS
Study Population
Five hundred forty-one patients (300 adults and 241 children) were enrolled in the study. Table 1 shows the baseline and injury characteristics, resuscitation data, outcomes, and complications for the adults (age ≥17 years). In general, adult survivors were younger with smaller burn sizes. When comparing the 2 adult age categories, the mortality rate in those patients aged 55 years or more was greater (38.5% vs 14.1%, P = 0.0001). In these adults, survival was not affected by sex, race, ethnicity, number of comorbidities, or mechanism of injury. Initial base deficit, lactate, and APACHE II scores were all significantly lower for those who survived. Fluid resuscitation volumes were greater than 6 mL/kg/% TBSA and comparable between survivors and nonsurvivors. Even at discharge, the adult patients remained seriously debilitated in that only 52% went directly home. Complications including pneumonia (47%), sepsis (10%), and nosocomial infections (70.7%) were common in these patients who experienced extended lengths of stay and numerous ventilator days. Presence of inhalation injury was associated with mortality (P = 0.0023) in this univariate analysis. Table 2 shows the baseline and injury characteristics, resuscitation data, outcomes, and complications for children (age <17 years). There was a trend, with females having a higher mortality rate (12.8% vs 5.5%, P = 0.0712). There was a strong statistical difference in mortality related to race (P = 0.0052). Ethnicity, comorbidities, and burn mechanism did not influence the likelihood of survival. Initial base deficit, lactate, and APACHE II scores were lower in those children who survived. As with the adults, average resuscitation fluid volumes exceeded 4 mL/kg/% TBSA, and the presence of inhalation injury was associated with mortality in children (P = 0.008).
As expected, there were multiple differences observed when comparing children and adults. When compared with adults, mortality (7.9% in children vs 14.1% in adults), frequency of complications, and frequency of comorbidities were all substantially lower despite a larger average burn size for the children, 57. 8 
Standard Operating Procedure Compliance
Regarding minimal urinary output, the fluid resuscitation SOP requires that average urinary output be 0.3 mL/kg/h or more. To be compliant, patients with urinary outputs of less than 0.3 mL/kg/h should have received 2 mL/kg/% TBSA or more over the first 24 hours. Compliance was excellent in that 97% of patients met the protocol criterion for both the first and second 24-hour time periods. However, compliance with the requirement of total fluid resuscitation volumes of 2 to 4 mL/kg/% TBSA was poor. Patients received more than the recommended fluid volumes for resuscitation, with 46% of patients receiving greater than 4 mL/kg/% TBSA over the first 24 hours. These compliance values remained stable over the course of the study.
Only 1% of the patients had a recorded mean arterial pressure of 60 mm Hg or less at any time during the first 24 hours postinjury in the settings of the prehospital setting, emergency department(s), transferring facility, or in the participating burn center.
With respect to the protocol for prevention of hyperglycemia, blood glucose levels could have been on-target (<180 mg/dL) or off-target (≥180 mg/dL) if the patient was receiving insulin. Approximately 22.9% of the patients had recorded blood glucose values off-target (≥180 mg/dL) and were not receiving insulin. Compliance with this SOP did not seem to change over the course of the study.
Comparative Outcomes
It has been well described that 3 factors strongly affect the probability of death from burn injuries-age, overall burn size, and presence of inhalation injury. Figure 1A shows a gradual, monotonic effect of age up to approximately 50 years with an inflection point between 50 and 60, indicating that the effect of age becomes more dominant. Similarly, Figure 1B shows a gradual, monotonic effect of burn size of 20% up to approximately 70% TBSA beyond which burn size seems to provide an even stronger effect. With respect to burn size, the LA50 (Lethal Area 50, burn area lethal in 50% of patients) is approximately 90% TBSA. When the adult and pediatric databases were combined, mortality was 19.5% for those with inhalation injury and 8.9% for those without. This difference in mortality has a calculated P < 0.0001 that is unadjusted for potential imbalances other than inhalation injury. Figure 2A shows an invariant mortality rate of approximately 14% over the course of our 7-year study. Figure 2B shows the comparison of mortality in TBSA quintiles of burn size for patients younger than versus older than 50 years in the NBR versus the current study, which suggests that there might be survival improvements in patients younger than 50 years with larger burns. In patients 50 years of age and older, there might be survival improvements in the smaller burns, but there does not seem to be any survival differences in older patients with very large burn injuries.
In a comparison of the data in this study versus patients in the NBR after excluding those with burn sizes less than 20% TBSA, a logistic regression stratified on age, burn size, and presence of inhalation injury was performed. Following these adjustments, there was a lower risk of mortality for patients in our current study [odds ratio (OR) = 0.71 (95% confidence interval: 0.53-0.97), P = 0.03]. An analysis of the mortality rate in the Glue cohort alone was based upon a model that predicts expected mortality rate in patients admitted to the Massachusetts General Hospital and Shriners Hospitals for Children-Boston, from 1990 to 1994. 6 The result of this model was highly consistent with the outcomes in this study and predicted that 74.09 deaths would occur versus the 74 deaths that actually occurred (Flora's score Z = −0.01, P = 0.9895). consistent with MOF, for periods up to 180 days postinjury. Deaths occurred soon after admission but continued to occur as many as 100 days postadmission. To the left of Figure 3A , there is a scatter plot of both age and burn size for each of the patients shown top to bottom. A smooth curve plots the centroids for each. Figure 3A shows that the average age increased from approximately 25 to 40 years and burn size increased from 40% to 70% TBSA from top to bottom of the figure. These findings are consistent with the finding that those patients with organ failure scores of 0 are younger and with more moderate-sized injuries. Figure 3B identifies 4 categories of patients that show that there were deaths occurring up to 90 to 100 days postinjury. There was gradual recovery for those patients with Denver scores of 1 to 3 and 4 or more (MOF) over the 180-day period. All patients had died or were recovered from organ failure or MOF by 180 days. MOF. Pulmonary dysfunction was the most common organ failure after burn injury, with nearly 63% of patients demonstrating some degree of pulmonary failure within the first 3 weeks (early organ failure) after admission and 31.0% after 3 weeks (late organ failure). During the early organ failure phase, cardiac failure was the second most common organ failure, with 29.9% of patients showing abnormal values. Hepatic and renal dysfunctions were uncommon, with only 13% (hepatic) and 16% (renal) of the patients demonstrating any abnormal values during the first 3 weeks. In comparison between adults and children, organ function values were different for each of the organs evaluated. There appeared to be greater cardiac (P = 0.0003), pulmonary (P = 0.0189), and hepatic (P = 0.00002) organ dysfunction and less renal (P = 0.0001) dysfunction in children than in adults. Given the greater degree of organ failure in children, it is surprising that the mortality rate was significantly different compared with adults. ARDS was diagnosed far more commonly in adults (P < 0.0001).
DISCUSSION
This benchmark study, which includes a well-characterized cohort of 541 burn patients, represents one of the first comprehensive, multi-institutional reports of patient and injury characteristics, anatomic and physiologic derangements, and outcomes from patients with severe burn injuries involving greater than 20% TBSA. It is difficult for any single institution to provide comparable data over a short time period due to the relative infrequency of larger burns managed with up-to-date evidence-based treatment protocols. Among other findings, this report challenges the relative importance of the 3 "traditional" risk factors for death from burn injury (burn size, age, and presence of inhalation injury). Furthermore, these data are Web-accessible at www.gluegrant.org and may serve for future large-scale injury research studies.
First, we show that a patient is more likely to survive today what previously was considered a lethal injury. In this cohort of patients with TBSA greater than 20%, the LA50 is approximately 90% TBSA, which represents a tremendous advancement compared to the 1960s to 1980s. In the 1940s, the comparable LA50 was more closely considered to be 20% TBSA, depending upon the ages of the underlying study population. These dramatic improvements in survival rates in the 1970s and 1980s were most likely related to advancements in surgical interventions and critical care support.
We have reached a plateau in survival rates until newer technologies or therapies become available to modify our current injury treatment paradigms. This is evident by the numbers of observed deaths in our current study comparing nearly identically with the predicted number of deaths from our previous 1998 report for patients admitted 1990 to 1994. 6 Furthermore, mortality in our study patients was reduced relative to NBR patients when stratified by the presence of inhalation injury, age, and total burn size. Using multivariate stratified logistic regression, there was a statistically significant 29% survival benefit for our patients in comparison with patients in the NBR. This comparison might suggest that standardized protocols provide a survival benefit. If indeed there are improvements in survival, our younger patients (<50 years of age) would be expected to survive larger burn injuries whereas those older patients (≥50 years of age) would be expected to survive more modest sized injuries.
The NBR comparison suffers from at least 1 weakness, a significant reduction in the number of eligible NBR patients remaining for direct comparison with our Glue Grant patients. This huge reduction stems from the fact that the NBR records are reported from all-comers to the North American burn centers whereas the Glue Grant study selected only those patients at serious risk for organ dysfunction and potential death. The original contemporary NBR data set contained 201,174 non-Glue Grant center records, and after excluding 45,972 records for emergency department visits only, readmissions, or nonburn injuries and excluding 4493 records missing essential patient data, the Glue Grant inclusion and exclusion criteria were applied to the remaining records, which reduced the NBR comparison set to fewer than 4700 patients.
The very important effect of age on mortality, when burn size and presence of inhalation injury are controlled, was found to be less profound in those patients younger than 55 years. The average mortality for patients younger than 17 years was 7.9% and for those 17 to 55 years was 14.1%, both of which seem lower than expected. The overall mortality for those patients aged 55 years and older was 38.5%. The significant inflection point in which age becomes a dominant factor for survival lies between 50 and 60 years. This is an important finding in that individuals, demonstrating depressed organ reserves at the time of initial injury, can be at least partially compensated by supportive medical care. This compensation tends to become increasingly limited above 60 years of age.
In our previous report, 6 inhalation injury was identified as a significant risk predictor and in the present analysis, it remains a significant predictor in both adults and children separately, and effects mortality no less even when adults and children are pooled (P > 0.0001). As a continuing major problem in burn injury affecting mortality, we could hope that inhalation injury might experience a similar decrease in incidence, morbidity, and mortality like ARDS in trauma patients, [18] [19] [20] which was believed to be due to enhanced compliance with improved ventilation strategies. In injured patients, previous modes of ventilatory support were shown to incite barotrauma and accentuate the host inflammatory response, which likely compounded the initial damage caused by inhalation injury.
There is a growing trend in health care to develop evidencebased protocols to evaluate a variety of medical and surgical treatments and for measuring quality of care. [21] [22] Our study provided a modest step toward the ultimate goal of an evidence-based SOP for resuscitation. It is apparent that greater than 4 mL/kg/% TBSA is routinely being administered to patients during the first 24 hours postburn injury and indeed that occurred both in our adults and children. This study provides no evidence that additional fluids either benefited or harmed the patient. At the very least, the additional fluids require more time to be reabsorbed in the days postinjury, and most of the additional fluids reside in the lungs. Using a propensity score logistic model and an earlier subset of patients from our study, the increased fluids resulted in statistically important increases in the risk of pneumonia (OR = 1.92), blood stream infections (OR = 2.33), ARDS (OR = 1.44), MOF (OR = 1.49), and death (OR = 1.74). 23 The National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome Clinical Trials Group performed a randomized trial of conservative versus liberal fluid treatment of acute lung injury, with the primary endpoint being death at 60 days. The secondary endpoints were ventilator-free days, organ-failure-free days, and measures of lung physiology.
In the ARDS Network study, there was no effect on 60-day mortality between the 2 fluid management strategies. However, the conservative strategy group did experience better lung function and fewer ventilator and intensive care days with no increase in nonpulmonary organ failures. 24 Similar trials with lower volume resuscitation, possibly with more liberal use of vasopressors to compensate for the inflammatory mediator-induced vasodilation, are called for in patients with major burns.
The MOF rate of 27% in our study is comparable with the MOF rate of 35% seen in patients with major blunt trauma. 25 This finding indicates that MOF remains a serious challenge in critically injured burn patients. The time required to recover (TTR) is potentially an important outcome measure. Given the overall high rate of MOF in children and in adults, we suggest that a better description is required, not only to describe organ dysfunction but also to quantify the dynamic nature for recovery from organ dysfunction.
The concept of TTR as an outcome benchmark is relatively new. We see at least 2 potential advantages: it has more clinical or bedside utility, and in our view, it is easier to recognize signs of multisystem organ recovery than arbitrary grades of organ dysfunction. A third potential advantage is increased power to detect treatment effects in randomized trials. TTR is similar to ventilator-free days in that it combines information on both mortality and speed of recovery in survivors. Ventilator-free days have been shown to be a more powerful outcome measure than mortality alone under various plausible scenarios.
CONCLUSIONS
In summary, this study serves as a benchmark in burn care. Today, burn patients are expected to survive what might have been highly lethal injuries a few decades ago. Organ dysfunction and other detrimental sequelae of burn and inhalation injury, such as pneumonia and blood stream infection, are now preventable and better treated. The importance of inhalation injury as a significant risk factor for mortality should continue to be recognized. We can certainly expect further improvements to come from, for example, better knowledge of resuscitation protocols and new surgical and critical care interventions. As more patients survive such devastating injuries and the concomitant conditions that often result, perhaps it is time to begin to focus more attention to the burn patient's quality-of-life domains (physical, psychological, and family) for those many patients who do survive.
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